"There's got to be room for OTC contracts between two consenting adults."

30 Oct 2009

--Jamie Dimon, ceo of JPMorgan Chase, speaking at the SIFMA annual conference in New York on the need to preserve customized derivatives under the proposed U.S. regulatory regime.



Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial